Natera, Inc. Asia Pacific and Other — Total revenues increased by 24.4% to $2.22M in Q1 2026 compared to the prior quarter. This is a positive signal — higher values indicate stronger performance for this metric.
An increase indicates successful market penetration and growing demand for genetic testing services in international regions, while a decrease may signal competitive pressure, regulatory hurdles, or challenges in local distribution partnerships.
This metric represents the total revenue generated from diagnostic testing services and research collaborations within t...
Peers in the molecular diagnostics space typically report international revenue as a distinct geographic segment to highlight global scaling efforts and exposure to different reimbursement environments.
ntra_segment_asia_pacific_and_other_total_revenues| Q1 '25 | Q1 '26 | |
|---|---|---|
| Value | $1.78M | $2.22M |
| QoQ Change | — | +24.4% |
| YoY Change | — | +24.4% |